CYP19A1 and breast carcinoma: Currently used targeted therapies against breast cancer include the use of tamoxifen, fulvestrant, and aromatase inhibitors for ER-positive breast cancers and Herceptin and HER2 inhibitors for the HER2-positive breast cancer treatment [29].